Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-24T22:42:49.195Z Has data issue: false hasContentIssue false

Sedatives

from Part II - Medication Reference Tables

Published online by Cambridge University Press:  19 October 2021

Edited by
Michael Cummings  and
Stephen Stahl
Michael Cummings
Affiliation:
University of California, Los Angeles
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Management of Complex Treatment-resistant Psychotic Disorders , pp. 370 - 392
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Stahl, S. M. (2017). Eszopiclone. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 261–264.Google Scholar
West-Ward Pharmaceuticals Corp. (2020). Eszopiclone Package Insert. West Eatontown, New Jersey.Google Scholar

References

Stahl, S. M. (2017). Oxazepam. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 537–541.Google Scholar
Frase, L., Nissen, C., Riemann, D., et al. (2018). Making sleep easier: pharmacological interventions for insomnia. Expert Opin Pharmacother, 19, 1465–1473.CrossRefGoogle ScholarPubMed
Aphena Pharma Solutions LLC. (2019). Oxazepam Package Insert. Cookville, Tennesee.Google Scholar
Volz, A., Khorsand, V., Gillies, D., et al. (2007). Benzodiazepines for schizophrenia. Cochrane Database Syst Rev, 11, CD006391.Google Scholar
Dold, M., Li, C., Tardy, M., et al. (2012). Benzodiazepines for schizophrenia. Cochrane Database Syst Rev, 11, CD006391.Google Scholar
Tiihonen, J., Suokas, J. T., Suvisaari, J. M., et al. (2012). Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry, 69, 476–483.CrossRefGoogle ScholarPubMed
Dold, M., Li, C., Gillies, D., et al. (2013). Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol, 23, 1023–1033.CrossRefGoogle ScholarPubMed
Gillies, D., Sampson, S., Beck, A., et al. (2013). Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev, 9, CD003079.Google Scholar
Dodds, T. J. (2017). Prescribed benzodiazepines and suicide risk: a review of the literature. Prim Care Companion CNS Disord, 19, doi: 10.4088Google Scholar
Zaman, H., Sampson, S., Beck, A., et al. (2018). Benzodiazepines for psychosis-induced aggression or agitation. Schizophr Bull, 44, 966–969.CrossRefGoogle ScholarPubMed
California Department of State Hospitals. (2019). DSH Psychotropic Medication Policy: Benzodiazepine Protocol. Sacramento, California.Google Scholar
Greenblatt, D. J. (1981). Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet, 6, 89–105.Google Scholar
Sonne, J., Loft, S., Døssing, M., et al. (1988). Bioavailability and pharmacokinetics of oxazepam. Eur J Clin Pharmacol, 35, 385–389.CrossRefGoogle ScholarPubMed
Ayd, F. J. Jr. (1990). Oxazepam: update 1989. Int Clin Psychopharmacol, 5, 1–15.CrossRefGoogle ScholarPubMed
Sonne, J., Boesgaard, S., Poulsen, H. E., et al. (1990). Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism. Br J Clin Pharmacol, 30, 737–742.Google Scholar

References

Stahl, S. M. (2017). Temazepam. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 703–706.Google Scholar
SpecGx LLC. (2020). Restoril Package Insert. Webster Groves, Montana.Google Scholar
Volz, A., Khorsand, V., Gillies, D., et al. (2007). Benzodiazepines for schizophrenia. Cochrane Database Syst Rev, 11, CD006391.Google Scholar
Dold, M., Li, C., Tardy, M., et al. (2012). Benzodiazepines for schizophrenia. Cochrane Database Syst Rev, 11, CD006391.Google ScholarPubMed
Tiihonen, J., Suokas, J. T., Suvisaari, J. M., et al. (2012). Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry, 69, 476–483.CrossRefGoogle ScholarPubMed
Dold, M., Li, C., Gillies, D., et al. (2013). Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol, 23, 1023–1033.Google Scholar
Gillies, D., Sampson, S., Beck, A., et al. (2013). Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev, 9, CD003079.Google Scholar
Dodds, T. J. (2017). Prescribed benzodiazepines and suicide risk: a review of the literature. Prim Care Companion CNS Disord, 19, doi: 10.4088CrossRefGoogle Scholar
Zaman, H., Sampson, S., Bec, A., et al. (2018). Benzodiazepines for psychosis-induced aggression or agitation. Schizophr Bull, 44, 966–969.CrossRefGoogle ScholarPubMed
California Department of State Hospitals. (2019). DSH Psychotropic Medication Policy: Benzodiazepine Protocol. Sacramento, California.Google Scholar
Liver Toxicology. (2012). Benzodiazepines. In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (eds.). Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases.Google Scholar
Stoehr, G. P., Kroboth, P. D., Juhl, R. P., et al. (1984). Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Clin Pharmacol Ther, 36, 683–690.CrossRefGoogle ScholarPubMed

References

Stahl, S. M. (2017). Zaleplon. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 803–806.Google Scholar
OrchidPharma Ltd. (2019). Zaleplon Package Insert. Chennai (India).Google Scholar

References

Stahl, S. M. (2017). Zolpidem. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 815–818.Google Scholar
ACI Healthcare USA. (2020). Zolpidem Package Insert. Colorado Springs, FloridaGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Sedatives
  • Edited by Michael Cummings, University of California, Los Angeles, Stephen Stahl, University of California, San Diego
  • Book: Management of Complex Treatment-resistant Psychotic Disorders
  • Online publication: 19 October 2021
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Sedatives
  • Edited by Michael Cummings, University of California, Los Angeles, Stephen Stahl, University of California, San Diego
  • Book: Management of Complex Treatment-resistant Psychotic Disorders
  • Online publication: 19 October 2021
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Sedatives
  • Edited by Michael Cummings, University of California, Los Angeles, Stephen Stahl, University of California, San Diego
  • Book: Management of Complex Treatment-resistant Psychotic Disorders
  • Online publication: 19 October 2021
Available formats
×